Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Canine Motilin (MTL) Polyclonal Antibody

Cat. No.VD11N863

Product TypeAnimal-targeted Antibodies

Size

Product Overview

BioVenic rabbit polyclonal antibody is specific for canine motilin. It is affinity purified by protein A. It can be applied to WB, IHC and IF/ICC assays of canine motilin.

Specifications

Application WB; IHC; IF/ICC
Clonality Polyclonal
Classification Primary Antibody
Clone J16N20
Host Rabbit
Target Species Canine
Species Reactivity Canine
Specificity Canine Motilin
Immunogen Recombinant protein of motilin
Purification Protein A Purified
Conjugation Unconjugated
Preservative and Stabilizer 0.05% Proclin 300
Buffer 0.01M Phosphate Buffered Saline, pH 7.4, 50% Glycerol
Physical State Liquid

Target Information

Canine motilin is a 22-amino acid peptide hormone that plays a crucial role in regulating gastrointestinal motility. It is secreted by endocrine cells of the intestinal mucosa and acts as a potent agonist for gastrointestinal smooth muscle contraction. In dogs, motilin also contracts the gallbladder and sphincter of Oddi and induces pancreatic secretion.

Target Canine Motilin
Target Synonym MTL
Gene ID 481748
UniProt ID P19863

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

  1. Kitazawa, Takio, and Hiroyuki Kaiya. "Motilin comparative study: structure, distribution, receptors, and gastrointestinal motility." Frontiers in Endocrinology 12 (2021): 700884.
Inquiry Basket